Circulation Research, Vol 38, 423-429, Copyright © 1976 by American Heart Association

ARTICLES

Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat

MA Pfeffer, JM Pfeffer and ED Frohlich

Cardiac pumping ability was assessed during the natural development of left ventricular hypertrophy by elevating venous pressure by infusing Tyrode's solution intravenously to produce peak cardiac output. This experiment was performed on spontaneously hypertensive rats (SHR) of three age groups (11, 24, and 83 weeks). From 11 to 24 weeks, peak cardiac output of SHR increased in direct proportion to the abnormally increased ventricular mass; Thus peak cardiac output per gram of left ventricle (LV) remained stable. Similar results were obtained for two strains of normotensive rats at each of the same three age groups. Thus, in the normotensive animal peak cardiac output per gram of LV remained stable over a wide range of ages and varying left ventricular weights. However, with progressive elevation of arterial pressure in aging SHR (83 weeks), we observed severe ventricular hypertrophy (100% increases in left ventricular to body weight ratio). In this oldest SHR group, unlike age-matched normotensive rats, there was a marked reduction in the pumping ability per gram of LV. Thus, during the natural development of left ventricular hypertrophy SHR demonstrated both a stable stage of hypertrophy in which the increased left ventricular mass maintained its pumping ability, and a later stage of deterioration in which there was a loss of the normal relationship between ventricular mass and pumping ability.

This article has been cited by other articles:

				M. Iemitsu, N. Shimojo, S. Maeda, Y. Irukayama-Tomobe, S. Sakai, T. Ohkubo, Y. Tanaka, and T. Miyauchi The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H136 - H144. [Abstract] [Full Text] [PDF]

				Y.-X. Shi, Y. Chen, Y.-Z. Zhu, G.-Y. Huang, P. K. Moore, S.-H. Huang, T. Yao, and Y.-C. Zhu Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2093 - H2100. [Abstract] [Full Text] [PDF]

				A. R. Allen, E. J. Kelso, D. Bell, Y. Zhao, P. Dickson, and B. J. McDermott Modulation of Contractile Function through Neuropeptide Y Receptors during Development of Cardiomyocyte Hypertrophy J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1286 - 1296. [Abstract] [Full Text] [PDF]

				G. R. Lee, D. Bell, E. J. Kelso, C. C. H. Argent, and B. J. McDermott Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H425 - H432. [Abstract] [Full Text] [PDF]

				B. Pilz, J.-H. Brasen, W. Schneider, and F. C. Luft Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A Harbinger of Things to Come Hypertension, May 1, 2004; 43(5): 911 - 917. [Full Text] [PDF]

				L. Lu, T. Yao, Y.-Z. Zhu, G.-Y. Huang, Y.-X. Cao, and Y.-C. Zhu Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial and intrarenal arteries in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1370 - H1377. [Abstract] [Full Text] [PDF]

				C. Morisco, J. Sadoshima, B. Trimarco, R. Arora, D. E. Vatner, and S. F. Vatner Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1043 - H1047. [Full Text] [PDF]

				S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy Physiol Genomics, April 10, 2002; 9(1): 43 - 48. [Abstract] [Full Text] [PDF]

				G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur. Heart J., October 2, 2000; 21(20): 1653 - 1665. [PDF]

				E. D. Frohlich Risk Mechanisms in Hypertensive Heart Disease Hypertension, October 1, 1999; 34(4): 782 - 789. [Abstract] [Full Text] [PDF]

				M. Obayashi, M. Yano, M. Kohno, S. Kobayashi, T. Tanigawa, K. Hironaka, T. Ryouke, and M. Matsuzaki Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1824 - H1831. [Abstract] [Full Text] [PDF]

				B. D. Hoit, Y. Shao, M. Gabel, and R. A. Walsh Disparate Effects of Early Pressure Overload Hypertrophy on Velocity-Dependent and Force-Dependent Indices of Ventricular Performance in the Conscious Baboon Circulation, February 15, 1995; 91(4): 1213 - 1220. [Abstract] [Full Text]

				C. H. Conrad, W. W. Brooks, J. A. Hayes, S. Sen, K. G. Robinson, and O. H. L. Bing Myocardial Fibrosis and Stiffness With Hypertrophy and Heart Failure in the Spontaneously Hypertensive Rat Circulation, January 1, 1995; 91(1): 161 - 170. [Abstract] [Full Text]

				S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy Physiol Genomics, April 10, 2002; 9(1): 43 - 48. [Abstract] [Full Text] [PDF]